Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
Go back to Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio| ANV Security Group, Inc. (NYSE: ANVS) | Delayed: 1.38 -0.32 (18.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $0.04 | |||
| Open | $1.65 | 52 Week Low | $0.01 | |||
| Day High | $1.68 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-0.03 | |||
| Volume | 7,297,123 | |||||
| ANV Security Group, Inc. (NYSE: ANVS) | Delayed: 1.38 -0.32 (18.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $0.04 | |||
| Open | $1.65 | 52 Week Low | $0.01 | |||
| Day High | $1.68 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-0.03 | |||
| Volume | 7,297,123 | |||||

